Responsive Image

 

 

Responsive Image

Alergias

Líneas de investigación

Alérgenos.

Biomarcadores en asma de difícil control.

Foto grupo

Actividades del grupo

  • Ensayos clínicos con Anti IL-5, S/C e inhalados, Inhibidores del JAK inhalados EN ASMA moderado y grave.
  • Ensayo clínico con Anti IL5 en esofagitis eosinofílica.
  • Ensayo clínico con Anti IgE en UCE.

Coordinador/a del grupo



Miembros del grupo

  Ana María Alonso Llamazares
 
 
  Fernando García González
 
 
  Elena Viguera Ortiz De Anda
 
 
  Bakai Matala Ahmed
 
 

Publicaciones del grupo

German Sanchez A, Alonso Llamazares A, Latorre Ibanez MD, Bartolome Zavala B, Antepara Ercoreca I. Sheep cheese allergy in Alpha-gal Syndrome. J Invest Allergol Clin Immunol. 2023. DOI:10.18176/jiaci.0897.

German Sanchez A, Alonso Llamazares A, Garcia Gonzalez F, Matala Ahmed B, Melgar Reyes CS, Antepara Ercoreca I. Diagnostic validity of specific immunoglobulin E levels to alpha-gal in alpha-gal syndrome: a cross-sectional analysis. Allerg Asthma Clin Immunol. 2023; 19(1): 102-102. DOI:10.1186/s13223-023-00856-6.

AntEpara I, Roger A, Bernedo N, Lleonart R, Rodriguez F, Madariaga B et al. Clinical trial to assess tolerability and subrogate efficacy effects of an abbreviated schedule with house dust mites mixture subcutaneous immunotherapy. Eur Ann Allergy Clin Immunol. 2021; 53(2): 67-74. DOI:10.23822/EurAnnACI.1764-1489.140.

German Sanchez A, Alonso Llamazares A, Garcia Gonzalez F, Matala Ahmed B, Bartolome Zavala B, Antepara Ercoreca I. Allergy to beer and wine caused by Saccharomyces cerevisiae in a patient sensitized to fungi. J Invest Allergol Clin Immunol. 2021: 0-0. DOI:10.18176/jiaci.0755.

Sanchez AG, Llamazares A, Gonzalez FG, Ahmed BM, Zavala BB, Ercoreca IA. Beer and wine allergy by sensitization to saccharomyces cerevisiae. Allergy. 2020; 75: 543-543

Martinez Moragon E, Delgado J, Mogrovejo S, Fernandez Sanchez T, Lopez JJ, Orenes M, et al. Factors that determine the loss of control when reducing therapy by steps in the treatment of moderate-severe asthma in standard clinical practice: A multicentre Spanish study. Rev Clin Esp. 2020; 220(2): 86-93. DOI:10.1016/j.rce.2019.05.004.

Giménez Arnau AM, Valero Santiago A, Bartra Tomás J, Jáuregui Presa I, Labrador Horrillo M, Miquel FJ, et al. Therapeutic strategy according to the differing patient response profiles to omalizumab in chronic spontaneous urticaria. J Invest Allergol Clin Immunol. 2019; 29(5): 338-348. DOI:10.18176/jiaci.0323.

Jauregui I, Sanchez J, Segurola A, Galan C, Seras Y, Gamboa PM. Allergic contact dermatitis by isobornyl acrylate in glucose monitoring devices: Report of two cases. Contact Dermatitis. 2019; 81(3): 219-220. DOI:10.1111/cod.13349.

Gamboa PM, Sánchez J, Segurola A, Galán C, García Lirio E, Seras Y, et al. Occupational contact dermatitis due to rosewood in a Basque wind instrument (txistu). Contact Dermatitis. 2019; 81(6): 450-451. DOI:10.1111/cod.13357.

Armario Hita JC, Pereyra Rodriguez J, Silvestre JF, Ruiz Villaverde R, Valero A, Izu Belloso R, et al. Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series. Br J Dermatol. 2019; 181(5): 1072-1074. DOI:10.1111/bjd.18041.

Sanchez J, Segurola A, Seras Y, Martinez MD, Irazabal MB, Jauregui I, et al. Tolerance to Iopamidol in Iomeprol allergic patients. Allergy. 2019; 74: 860-861

Sanchez J, Segurola A, Seras Y, Gamboa PM, Martinez MD, Irazabal MB, et al. Cross reactivity to cephalosporins and carbapenems in penicillin allergic patients. Allergy. 2019; 74: 860-860

Jáuregui I, Segurola A, Seras Y, Sánchez Vicente J, Martínez Antón M-D, Irazábal B, et al. Urticaria crónica y factores psicosociales: Reconocimiento, diagnóstico y manejo. Gac Med Bilbao. 2019; 116(4): 174-180

 

 

Responsive Image

Plaza Cruces S/N | 48903 Barakaldo
Tel.: 94 618 85 00

© 2024 IIS Biobizkaia